eprintid: 100046
rev_number: 3
eprint_status: archive
dir: disk0/00/10/00/46
datestamp: 2026-06-19 08:00:40
lastmod: 2026-06-19 08:00:40
status_changed: 2026-06-19 08:00:40
type: article
metadata_visibility: show
creators_name: G`opirjonova D.D, G`opirjonova D.D
creators_name: Alyavi A.L, Alyavi A.L
title: ENDOTHELIN-1 IN PATIENTS WITH ISCHEMIC HEART DISEASE
ispublished: pub
keywords: ischemic heart disease, endothelin-1, inflammation, biomarkers, neurohormanal activation.
abstract: Ishemia or ischemic heart disease is the leading cause of disability and premature deaths worldwide. IHD is a condition in which the heartis starved of oxygen due to a redused blood spply. Deapite a large pool of interesting candidate biomarkers, endothelin-1 (ET-1) appears to be involvedin multiple aspecis of IHD pathogenesis that include neurohormonal activation, cardiac remodeling, endothelial dysfunction, inflammation, atherosclerosis and alteration of the renal function. ET-1 production and release can be upregulated by inflammatory factors, such as IFN-γ and IL-1β, during disease
date: 2024-05-15
official_url: https://universalpublishings.com/index.php/cusr/article/view/5720
full_text_status: public
publication: "Conference on Universal Science Research 2023"
volume: 2
number: 5
pagerange: 96-97
citation:   G`opirjonova D.D, G`opirjonova D.D, Alyavi A.L, Alyavi A.L  (2024) ENDOTHELIN-1 IN PATIENTS WITH ISCHEMIC HEART DISEASE.  "Conference on Universal Science Research 2023", 2 (5).  pp. 96-97.      
document_url: https://arxiv.universalpublishings.com/id/eprint/100046/1/96-97_G_opirjonova_D_KONFERENSIYA_CUSR.pdf